Legal Representation
Attorney
Robert M. O'Connell, Jr.
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 23, 2018 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 23, 2018 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 23, 2018 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Apr 23, 2018 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jan 9, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 9, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 8, 2017 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Sep 5, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 5, 2017 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 10, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 8, 2017 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Feb 8, 2017 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Feb 8, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 2, 2016 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Sep 30, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 30, 2016 | NOAC | E | CORRECTED NOA E-MAILED | Loading... |
| Sep 29, 2016 | DPCC | D | DIVISIONAL PROCESSING COMPLETE | Loading... |
| Sep 6, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 3, 2016 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 15, 2016 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED | Loading... |
| Aug 15, 2016 | DRRR | I | DIVISIONAL REQUEST RECEIVED | Loading... |
| Aug 15, 2016 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Aug 15, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 15, 2016 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 15, 2016 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 12, 2016 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 11, 2016 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 15, 2016 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Mar 15, 2016 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 22, 2015 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 21, 2015 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 21, 2015 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 9, 2015 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Sep 9, 2015 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 17, 2015 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 20, 2015 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jan 20, 2015 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jan 7, 2015 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 31, 2014 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 13, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Dec 11, 2014 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 11, 2014 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Dec 11, 2014 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 11, 2014 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Dec 11, 2014 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 11, 2014 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 11, 2014 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Nov 25, 2014 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Nov 13, 2014 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Nov 12, 2014 | ALIE | A | ASSIGNED TO LIE | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, medicines, biologics, biotherapeutics, biosimilars and therapeutics, namely, nucleic acid therapeutics and polypeptide therapeutics for use in oncology
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"MESSENGER THERAPEUTICS"